
    
      A Multi-Center, Consecutively Enrolled Single-Arm Study to confirm the safety and
      effectiveness of the delivery of supersaturated oxygen (SSO2) Therapy for 60 minutes
      selectively into the left main coronary artery (LMCA) with a commercially available qualified
      SSO2 delivery catheter used with the TherOx® DownStream® System and Cartridge in the
      treatment of qualified patients presenting with anterior acute myocardial infarction in whom
      reperfusion with PCI is successful within six hours after symptom onset.
    
  